NCT02540187View on ClinicalTrials.gov

Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients

CompletedOBSERVATIONAL
Enrollment

164

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Hemophilia
Interventions
OTHER

blood specimen

Trial Locations (7)

42055

CHU Saint-Etienne, Saint-Etienne

Unknown

CHRU Lille, Lille

HCL, Lyon

AP-HM, Marseille

Chu Nancy, Nancy

Chu Reims, Reims

Chu Tours, Tours

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT02540187 - Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients | Biotech Hunter | Biotech Hunter